|
Fisk, B; Blevins, T L; Wharton, J T et al. (1995) Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines. J Exp Med 181:2109-17
|
|
Fisk, B; Ioannides, C G; Aggarwal, S et al. (1994) Enhanced expression of HLA-A,B,C and inducibility of TAP-1, TAP-2, and HLA-A,B,C by interferon-gamma in a multidrug-resistant small cell lung cancer line. Lymphokine Cytokine Res 13:125-31
|
|
Fisk, B; Chesak, B; Pollack, M S et al. (1994) Oligopeptide induction of a cytotoxic T lymphocyte response to HER-2/neu proto-oncogene in vitro. Cell Immunol 157:415-27
|
|
Fisk, B; Flytzanis, C N; Pollack, M S et al. (1994) Characterization of T-cell receptor V beta repertoire in ovarian tumour-reacting CD3+ CD8+ CD4- CTL lines. Scand J Immunol 40:591-600
|
|
Ioannides, C G; Whiteside, T L (1993) T cell recognition of human tumors: implications for molecular immunotherapy of cancer. Clin Immunol Immunopathol 66:91-106
|
|
Ioannides, C G; Fisk, B; Fan, D et al. (1993) Cytotoxic T cells isolated from ovarian malignant ascites recognize a peptide derived from the HER-2/neu proto-oncogene. Cell Immunol 151:225-34
|
|
Ioannides, C G; Ioannides, M G; O'Brian, C A (1992) T-cell recognition of oncogene products: a new strategy for immunotherapy. Mol Carcinog 6:77-82
|
